Neutrogena Skin Clearing Blemish Concealer - Buff 09
Salicylic Acid
Johnson & Johnson Consumer Inc.
Human Otc Drug
NDC 10812-520Neutrogena Skin Clearing Blemish Concealer - Buff 09 also known as Salicylic Acid is a human otc drug labeled by 'Johnson & Johnson Consumer Inc.'. National Drug Code (NDC) number for Neutrogena Skin Clearing Blemish Concealer - Buff 09 is 10812-520. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Neutrogena Skin Clearing Blemish Concealer - Buff 09 drug includes Salicylic Acid - 5.5 mg/g . The currest status of Neutrogena Skin Clearing Blemish Concealer - Buff 09 drug is Active.
Drug Information:
| Drug NDC: | 10812-520 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Neutrogena Skin Clearing Blemish Concealer - Buff 09 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Proprietary Name Base: | Neutrogena |
| The base of the Brand/Proprietary name excluding its suffix. |
| Proprietary Name Suffix: | Skin Clearing Blemish Concealer - Buff 09 |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Salicylic Acid |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Johnson & Johnson Consumer Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SALICYLIC ACID - 5.5 mg/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 05 Feb, 2010 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part333D |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Johnson & Johnson Consumer Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0086800105107
0086800105053
0086800105091
0086800105152
|
| UPC stands for Universal Product Code. |
| UNII: | O414PZ4LPZ
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 10812-520-01 | 1 APPLICATOR in 1 BLISTER PACK (10812-520-01) / 1.4 g in 1 APPLICATOR | 05 Feb, 2010 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose acne medication
Product Elements:
Neutrogena skin clearing blemish concealer - buff 09 salicylic acid water cyclomethicone 5 dimethicone kaolin cyclomethicone vinylpyrrolidone/hexadecene copolymer cetyl peg/ppg-10/1 dimethicone (hlb 5) trisiloxane bis-peg/ppg-14/14 dimethicone cyclomethicone 6 butylene glycol silicon dioxide phenoxyethanol boron nitride dimethicone/vinyl dimethicone crosspolymer (soft particle) sodium chloride magnesium sulfate, unspecified form propylene glycol methylparaben farnesol chamomile propylene carbonate triethoxycaprylylsilane propylparaben aloe vera leaf .alpha.-tocopherol acetate cocamidopropyl propylene glycol-dimonium chloride phosphate cetyl lactate c12-15 alkyl lactate benzalkonium chloride vitamin a palmitate pantothenic acid ascorbic acid titanium dioxide ferric oxide red salicylic acid salicylic acid neutrogena skin clearing blemish concealer - fair 05 salicylic acid water cyclomethicone 5 dimethicone kaolin cyclomethicone vinylpyrrolidone/hexadecene copolymer cetyl peg/ppg-10/1 dimethicone (hlb 5) trisiloxane bis-peg/ppg-14/14 dimethicone cyclomethicone 6 butylene glycol silicon dioxide phenoxyethanol boron nitride dimethicone/vinyl dimethicone crosspolymer (soft particle) sodium chloride magnesium sulfate, unspecified form propylene glycol methylparaben farnesol chamomile propylene carbonate triethoxycaprylylsilane propylparaben aloe vera leaf .alpha.-tocopherol acetate cocamidopropyl propylene glycol-dimonium chloride phosphate cetyl lactate c12-15 alkyl lactate benzalkonium chloride vitamin a palmitate pantothenic acid ascorbic acid titanium dioxide ferric oxide red salicylic acid salicylic acid neutrogena skin clearing blemish concealer - light 10 salicylic acid water cyclomethicone 5 dimethicone kaolin cyclomethicone vinylpyrrolidone/hexadecene copolymer cetyl peg/ppg-10/1 dimethicone (hlb 5) trisiloxane bis-peg/ppg-14/14 dimethicone cyclomethicone 6 butylene glycol silicon dioxide phenoxyethanol boron nitride dimethicone/vinyl dimethicone crosspolymer (soft particle) sodium chloride magnesium sulfate, unspecified form propylene glycol methylparaben farnesol chamomile propylene carbonate triethoxycaprylylsilane propylparaben aloe vera leaf .alpha.-tocopherol acetate cocamidopropyl propylene glycol-dimonium chloride phosphate cetyl lactate c12-15 alkyl lactate benzalkonium chloride vitamin a palmitate pantothenic acid ascorbic acid titanium dioxide ferric oxide red salicylic acid salicylic acid neutrogena skin clearing blemish concealer - medium 15 salicylic acid titanium dioxide ferric oxide red salicylic acid salicylic acid water cyclomethicone 5 dimethicone kaolin cyclomethicone vinylpyrrolidone/hexadecene copolymer cetyl peg/ppg-10/1 dimethicone (hlb 5) trisiloxane bis-peg/ppg-14/14 dimethicone cyclomethicone 6 butylene glycol silicon dioxide phenoxyethanol boron nitride dimethicone/vinyl dimethicone crosspolymer (soft particle) sodium chloride magnesium sulfate, unspecified form propylene glycol methylparaben farnesol chamomile propylene carbonate triethoxycaprylylsilane propylparaben aloe vera leaf .alpha.-tocopherol acetate cocamidopropyl propylene glycol-dimonium chloride phosphate cetyl lactate c12-15 alkyl lactate benzalkonium chloride vitamin a palmitate pantothenic acid ascorbic acid
Indications and Usage:
Use for the treatment of acne.
Warnings:
Warnings for external use only. when using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time. if eye contact occurs, flush thoroughly with water. keep out of reach of children . if swallowed, get medical help or contact a poison control center right away.
When Using:
When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time. if eye contact occurs, flush thoroughly with water.
Dosage and Administration:
Directions cleanse skin thoroughly before applying this product cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Package Label Principal Display Panel:
Principal display panel - 1.4 g applicator blister pack - buff 09 buff 09 skinclearing blemish concealer don't just cover up. clear up! powered by micro clear ® ------technology--------- blemish treatment with salicylic acid conceals and treats blemishes natural- looking coverage neutrogena net wt 0.05 oz. (1.4g) principal display panel - 1.4 g applicator blister pack - buff 09
Principal display panel - 1.4 g applicator blister pack - fair 05 fair 05 skinclearing blemish concealer don't just cover up. clear up! powered by micro clear ® ------technology--------- blemish treatment with salicylic acid conceals and treats blemishes natural- looking coverage neutrogena net wt 0.05 oz. (1.4g) principal display panel - 1.4 g applicator blister pack - fair 05
Principal display panel - 1.4 g applicator blister pack - light 10 light 10 skinclearing blemish concealer don't just cover up. clear up! powered by micro clear ® ------technology--------- blemish treatment with salicylic acid conceals and treats blemishes natural- looking coverage neutrogena net wt 0.05 oz. (1.4g) principal display panel - 1.4 g applicator blister pack - light 10
Principal display panel - 1.4 g applicator blister pack - medium 15 medium 15 skinclearing blemish concealer don't just cover up. clear up! powered by micro clear ® ------technology--------- blemish treatment with salicylic acid conceals and treats blemishes natural- looking coverage neutrogena net wt 0.05 oz. (1.4g) principal display panel - 1.4 g applicator blister pack - medium 15
Further Questions:
Questions? call toll-free 800-480-4812 or 215-273-8755 (collect) or visit www.neutrogena.com